United Kingdom · Series C startup
Funding summaryUpdated 26 Oct 2026
$400Mraised across 2 rounds since 2021, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by UCL Technology Fund
Reported by UCL Technology Fund
Apollo Therapeutics filed one raise, $206M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Apollo Therapeutics's own website: 8 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Patient Square CapitalLL
Rock Springs Capital
UCL Technology Fund
Reimagined VenturesM&G plcMissing a round, or an investor who was in one? Tell us.
This firm lists Apollo Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Apollo Therapeutics's investors include Patient Square Capital, Rock Springs Capital, UCL Technology Fund, Reimagined Ventures and M&G plc. Patient Square Capital led its latest round.
Apollo Therapeutics has raised $400M across 2 rounds since 2021.
Apollo Therapeutics's most recent round was a Series C of $260M in Jan 2024, led by Patient Square Capital.
Its most recent round, $260M in Jan 2024, is also its largest on record.
Apollo Therapeutics's first round on record, in Jun 2021, was backed by Patient Square Capital, Rock Springs Capital and UCL Technology Fund and 1 others.
Apollo Therapeutics's latest named round is a Series C, in Jan 2024.
Apollo Therapeutics is based in the United Kingdom.
Patient Square Capital led the Series A in 2021.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
